Mirae Asset Global Investments’s Precigen PGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$90.9K Sell
15,944
-2,511
-14% -$10.9K ﹤0.01% 1255
2026
Q1
$71.4K Buy
18,455
+1,261
+7% +$5.17K ﹤0.01% 1231
2025
Q4
$71.9K Buy
17,194
+5,674
+49% +$22K ﹤0.01% 1323
2025
Q3
$37.9K Buy
11,520
+117
+1% +$330 ﹤0.01% 1388
2025
Q2
$16.2K Buy
11,403
+1,603
+16% +$2.28K ﹤0.01% 1422
2025
Q1
$15.6K Buy
9,800
+41
+0.4% +$65 ﹤0.01% 1414
2024
Q4
$7.09K Sell
9,759
-647
-6% -$552 ﹤0.01% 1537
2024
Q3
$9.85K Buy
10,406
+2,870
+38% +$3.62K ﹤0.01% 1497
2024
Q2
$11.4K Buy
+7,536
New +$10.9K ﹤0.01% 1452

Other funds holding PGEN

Mirae Asset Global Investments's PGEN Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Precigen (PGEN) stake by 14% in Q2 2026, selling an estimated $10.9K and leaving 15,944 shares worth $90.9K. The position accounts for ﹤0.01% of the portfolio, ranked #1255.

Mirae Asset Global Investments first reported a position in PGEN in Q2 2024 and has held it in 9 quarters since. 211 funds tracked by Wall St. Rank hold PGEN as of Q2 2026.

  • Mirae Asset Global Investments held 15,944 shares of Precigen worth $90.9K as of Q2 2026.
  • Mirae Asset Global Investments sold 2,511 Precigen shares in Q2 2026, an estimated $10.9K.
  • Precigen made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1255 holding.
  • Mirae Asset Global Investments first reported a position in Precigen in Q2 2024 and has held it in 9 quarters since.
  • 211 funds tracked by Wall St. Rank held Precigen as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.